v3.25.3
Stockholders' Equity
9 Months Ended
Sep. 30, 2025
Equity [Abstract]  
Stockholders' Equity

7. Stockholders’ Equity

Shelf Registration Statement and ATM Offering Program

On November 1, 2022, the Company filed a registration statement on Form S-3 with the SEC for the issuance of common stock, preferred stock, warrants, debt securities, rights and units up to an aggregate of $250.0 million. On November 14, 2022, the registration statement was declared effective by the SEC. The registration statement includes an ATM offering program for the sale of up to $125.0 million of shares of the Company’s common stock.

During the three and nine months ended September 30, 2025, the Company did not sell any shares of common stock under the ATM offering program. As of September 30, 2025, the Company had $106.2 million of remaining capacity available under the ATM facility.

Preferred Stock

There were no issued and outstanding shares of preferred stock as of September 30, 2025 and December 31, 2024.

Common Stock

Voting, dividend and liquidation rights of the holders of the common stock are subject to and qualified by the rights, powers and preferences of the holders of the preferred stock.

Voting—Each holder of outstanding shares of common stock shall be entitled to one vote in respect of each share.

Reserved SharesThe Company reserved the following shares of common stock for issuance:

 

September 30, 2025

 

 

December 31, 2024

 

Stock options outstanding

 

12,580,264

 

 

 

9,711,075

 

Restricted stock units outstanding

 

1,800,089

 

 

 

2,463,601

 

Shares reserved for future issuance

 

5,134,310

 

 

 

4,295,342

 

Pre-Funded Warrant Shares

 

 

 

 

1,611,215

 

Apexigen replacement warrants

 

1,003,191

 

 

 

1,003,191

 

Employee stock purchase plan

 

653,777

 

 

 

573,316

 

Total

 

21,171,631

 

 

 

19,657,740